Services do NOT include

Fill and finish.

Possible Output

A GMP documented and QA released antigen to be used in vaccine formulation.

Sample Requirements - input of users

Aminoacid sequence and requirements for antigen characteristics, (folding, size, aggregation).

Lead Scientist

Charlotte Green Jensen

Description of service

GMP production of recombinant vaccine candidates for clinical trials phase I/II. SSI offers Manufacture of GMP master/working cell banks and manufacture of clinical-grade vaccine candidate (drug substance).

Timeline 

12 months

Contact 

Ingrid Kromann

IKR@ssi.dk

0045 32688252.

GMP production services of recombinant vaccine candidates for clinical trials phase I/II

Paid Service